The main aim of this study was to screen the male patients with breast cancer for BRCA1 and BRCA2 mutations as well as the status of tissue tumor markers including ER, PR, HER-2 and basal marker (CK5/6). The gene discussed is BRCA2; the disease is breast carcinoma.